Clinical Study

Assessment of Histopathological Response in Gastric and Gastro-Oesophageal Junction Adenocarcinoma following Neoadjuvant Chemotherapy: Which Scoring System to Use?

Table 1

Histological response criteria following neoadjuvant chemotherapy in gastric cancers.

ReferenceScoresCriteria

TRG 1Absence of residual cancer and fibrosis extending through the layers of oesophageal wall
TRG 2Presence of rare residual cancer cells
Mandard et al. [7] TRG 3Increase in number of residual cancer cells, but fibrosis still predominant
TRG 4Showing residual cancer out-growing fibrosis
TRG 5Absence of regressive changes

Grade 0No change ± neither necrosis nor cellular or structural change can be seen throughout the lesion
Ninomiya et al. [10]
Grade 11(a) Necrosis or disappearance of the tumour is present in less than 1/3 of the whole lesion
1(b) Necrosis or disappearance of the tumour is present in no more than 2/3 of the whole lesion
Grade 2Moderate change ± necrosis or disappearance of the tumour is present in more than 2/3 of the whole lesion, but viable tumour cells remain.
Grade 3Marked change ± the whole lesion falls into necrosis and/or is replaced by fibrosis, with or without granulomatous changes. No viable tumour cells.

Becker et al. [11]1ANo residual tumour/tumour bed
1B<10% tumour cells
210–50% residual tumour/tumour bed
3>50% no signs of neoplastic regression